Literature DB >> 30767747

Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review.

Abdul Hamid Al Ghamdi1.   

Abstract

OBJECTIVE: This study was conducted to discuss the clinical value of published Diabetic Retinopathy Progression determinants.
METHODS: The data for systematic review was collected from the published studies through PubMed and Medline. These studies discussed the clinical predictors of Diabetic Retinopathy (DR) progression. The common keywords used were diabetic Retinopathy, diabetes mellitus, systolic blood pressure, hemoglobin, and albuminuria.
RESULTS: Diabetic Retinopathy is one of the common causes of irreversible visual impairment among adults. Poor glycemic control, systemic hypertension, diabetes duration, dyslipidemia, and microalbuminuria are the major risk factors for the development and progression of diabetic retinopathy. Recently, increased aortic stiffness has been identified as a prognostic marker of diabetic retinopathy and peripheral neuropathy.
CONCLUSION: Certain groups of diabetic individuals are at higher risk to have progressive diabetic retinopathy and eventually visual impairment. Clinical determinants and predictors are considered as prognostic markers and could help physicians to develop an effective risk-based screening program for this condition. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Diabetic retinopathy; albuminuria; diabetes mellitus; hemoglobin; systematic review; systolic blood pressure.

Year:  2020        PMID: 30767747     DOI: 10.2174/1573399815666190215120435

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  10 in total

1.  Long noncoding RNA PVT1 regulates the proliferation and apoptosis of ARPE-19 cells in vitro via the miR-1301-3p/KLF7 axis.

Authors:  Jianjin Guo; Yuan Chen; Jiajia Xu; Liqi Li; Wenjiao Dang; Feng Xiao; Wei Ren; Yikun Zhu; Qiujing Du; Qian Li; Xing Li
Journal:  Cell Cycle       Date:  2022-04-22       Impact factor: 5.173

2.  Impact of Long Noncoding RNA LINC00673 Genetic Variants on Susceptibility to Diabetic Retinopathy.

Authors:  Chih-Chun Chuang; Yi-Sun Yang; Edy Kornelius; Chien-Ning Huang; Min-Yen Hsu; Chia-Yi Lee; Shun-Fa Yang
Journal:  Front Genet       Date:  2022-04-25       Impact factor: 4.772

3.  [Wogonoside alleviates high glucose-induced dysfunction of retinal microvascular endothelial cells and diabetic retinopathy in rats by up-regulating SIRT1].

Authors:  X Shao; J Yu; W Ni
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-04-20

4.  Association of Long Non-Coding RNA Growth Arrest-Specific 5 Genetic Variants with Diabetic Retinopathy.

Authors:  Chee-Ming Lee; Yi-Sun Yang; Edy Kornelius; Chien-Ning Huang; Min-Yen Hsu; Chia-Yi Lee; Shu-Yen Peng; Shun-Fa Yang
Journal:  Genes (Basel)       Date:  2022-03-25       Impact factor: 4.141

5.  Changes and significance of retinal blood oxygen saturation and oxidative stress indexes in patients with diabetic retinopathy.

Authors:  Xiao-Li Wang; Fang-Rong Cai; Yun-Xia Gao; Jian Zhang; Ming Zhang
Journal:  World J Diabetes       Date:  2022-05-15

Review 6.  Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses.

Authors:  Hao Wu; Vikram Norton; Kui Cui; Bo Zhu; Sudarshan Bhattacharjee; Yao Wei Lu; Beibei Wang; Dan Shan; Scott Wong; Yunzhou Dong; Siu-Lung Chan; Douglas Cowan; Jian Xu; Diane R Bielenberg; Changcheng Zhou; Hong Chen
Journal:  Front Cardiovasc Med       Date:  2022-02-17

7.  Trimetazidine mitigates high glucose-induced retinal endothelial dysfunction by inhibiting PI3K/Akt/mTOR pathway-mediated autophagy.

Authors:  Qingsong Yang; Sizhen Li; Zixiu Zhou; Xiaodong Yang; Yating Liu; Kuanxiao Hao; Min Fu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

8.  Prevalence of and risk factors for diabetic retinopathy in residents with different types of abnormal glucose metabolism with or without hypertension: A suburban community-based cross-sectional study.

Authors:  Yuhang Ma; Hao Wang; Junyi Jiang; Changjing Han; Chunhua Lu; Siliang Zeng; Yufan Wang; Zhi Zheng; Yongde Peng; Xiaoying Ding
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-08       Impact factor: 6.055

9.  Prognostic Evaluation of Vitrectomy Assisted by Lucentis in Diabetic Retinopathy and Neovascular Glaucoma.

Authors:  Xuli Zhao; Yakun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-01       Impact factor: 2.650

Review 10.  The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis.

Authors:  Chao Huang; Haiqing Ji; Xuguang Han
Journal:  J Ophthalmol       Date:  2021-05-08       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.